We are live on ! Find out more
LTFS

Ladenburg Thalmann Financial Services Portfolio holdings

AUM $15.9B
1-Year Est. Return 27.61%
This Fund
S&P 500
This Quarter Est. Return
+5.57%
1 Year Est. Return
+27.61%
3 Year Est. Return
+43.58%
5 Year Est. Return
+60.23%
10 Year Est. Return
AUM
$12B
AUM Growth
+$1.22B
Cap. Flow
+$501M
Cap. Flow %
4.19%
Top 10 Hldgs %
14.03%
Holding
5,659
New
398
Increased
2,164
Reduced
2,101
Closed
385
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSII
4226
DELISTED
Heidrick & Struggles
HSII
$11K ﹤0.01%
350
IMRN
4227
Immuron
IMRN
$9.12M
$11K ﹤0.01%
1,200
-800
-40% -$8.08K
INDS icon
4228
Pacer Industrial Real Estate ETF
INDS
$116M
$11K ﹤0.01%
+459
New +$11.7K
KEQU icon
4229
Kewaunee Scientific
KEQU
$105M
$11K ﹤0.01%
364
KNDI
4230
Kandi Technologies Group
KNDI
$64.4M
$11K ﹤0.01%
2,280
+1,000
+78% +$4.25K
KOS icon
4231
Kosmos Energy
KOS
$1.51B
$11K ﹤0.01%
+1,134
New +$9.58K
LPCN icon
4232
Lipocine
LPCN
$17M
$11K ﹤0.01%
450
-100
-18% -$2.46K
MFG icon
4233
Mizuho Financial
MFG
$134B
$11K ﹤0.01%
3,266
-2,234
-41% -$7.8K
PLUS icon
4234
ePlus
PLUS
$2.31B
$11K ﹤0.01%
246
-38
-13% -$1.9K
PNF
4235
DELISTED
PIMCO New York Municipal Income Fund
PNF
$11K ﹤0.01%
906
POST icon
4236
Post Holdings
POST
$3.65B
$11K ﹤0.01%
167
+81
+94% +$4.97K
PRGS icon
4237
Progress Software
PRGS
$1.83B
$11K ﹤0.01%
300
-1,075
-78% -$42.7K
PST icon
4238
ProShares Trust UltraShort Lehman 7-10 Year Treasury
PST
$10.5M
$11K ﹤0.01%
464
-282
-38% -$6.47K
RCUS icon
4239
Arcus Biosciences
RCUS
$3.67B
$11K ﹤0.01%
790
RNAC icon
4240
Cartesian Therapeutics
RNAC
$264M
$11K ﹤0.01%
+23
New +$9.24K
SGRY icon
4241
Surgery Partners
SGRY
$1.99B
$11K ﹤0.01%
679
-2,895
-81% -$46.2K
SPXT icon
4242
ProShares S&P 500 ex-Technology ETF
SPXT
$293M
$11K ﹤0.01%
205
SSB icon
4243
SouthState Bank Corp
SSB
$10.8B
$11K ﹤0.01%
140
-138
-50% -$11.7K
TBX icon
4244
ProShares Short 7-10 Year Treasury
TBX
$20.8M
$11K ﹤0.01%
362
VOC icon
4245
VOC Energy
VOC
$55.8M
$11K ﹤0.01%
2,000
YORW icon
4246
York Water
YORW
$536M
$11K ﹤0.01%
363
-2,948
-89% -$90.9K
MTEM
4247
DELISTED
Molecular Templates, Inc.
MTEM
$11K ﹤0.01%
138
BLCM
4248
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$11K ﹤0.01%
161
+100
+164% +$6.77K
NBEV
4249
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$11K ﹤0.01%
2,000
+300
+18% +$680
NBLX
4250
DELISTED
Noble Midstream Partners LP
NBLX
$11K ﹤0.01%
300

Similar funds

Ladenburg Thalmann Financial Services's Q3 2018 Portfolio in Review

As of Q3 2018, Ladenburg Thalmann Financial Services held 5,659 positions worth $12B, up 11% from $10.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Ladenburg Thalmann Financial Services deployed $501M of net new capital in Q3 2018, opening 398 new positions and adding to 2,164 existing holdings. Its largest new stake was Invesco Ultra Short Duration ETF: 480,696 shares worth $24.1M.

By sector, the portfolio is most concentrated in Technology at 7.2% of assets, up from 6.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares MSCI USA Momentum Factor ETF, an estimated $58.2M trimmed.

  • Ladenburg Thalmann Financial Services's largest Q3 2018 buy was Invesco Ultra Short Duration ETF: 480,696 shares worth $24.1M.
  • Ladenburg Thalmann Financial Services added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q3 2018, an estimated $86.6M increase.
  • Ladenburg Thalmann Financial Services's biggest Q3 2018 reduction was iShares MSCI USA Momentum Factor ETF, cutting an estimated $58.2M.
  • Ladenburg Thalmann Financial Services fully exited CLAYMORE US CAPITAL MARKETS MICRO-TERM FIXED INCOME ETF in Q3 2018, selling an estimated $28.5M.
  • Ladenburg Thalmann Financial Services's ten largest holdings make up 14% of its $12B portfolio in Q3 2018.
  • Ladenburg Thalmann Financial Services opened 398 new positions and closed 385 in Q3 2018.
  • Ladenburg Thalmann Financial Services's portfolio value rose 11% quarter-over-quarter to $12B.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2018, filed 14 Nov 2018.